Quick Takeaways
- Paul L. Berns filed SCHEDULE 13G/A for Neumora Therapeutics, Inc. Common Stock par value $0.0001 per share (NMRA).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2024.
Paul L. Berns - 31 Dec 2024 SCHEDULE 13G/A Report for Neumora Therapeutics, Inc. Common Stock par value $0.0001 per share (NMRA)
- Filing Manager
- Paul L. Berns
- Reporting Manager
- Paul L Berns
- Symbol
- NMRA
- Shares outstanding
- 161,299,451 shares
- Disclosed Ownership
- 8,226,272 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2025, 16:30:02 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Paul L. Berns disclosed 5.1% ownership in Neumora Therapeutics, Inc. Common Stock par value $0.0001 per share (NMRA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paul L Berns | 5.1% | 8,226,272 | 8,226,272 | 0 | /s/ Paul L. Berns | Paul L. Berns |